Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01900964 · ClinicalTrials.gov registry record · NA
Ridge Preservation Comparing a PTFE Nonresorbable Membrane to a Collagen Membrane
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01900964: Completed NA study, sponsored by University of Louisville.
NCT01900964 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01900964, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
A non-resorbable PTFE (teflon) membrane will be compared to a resorbable collagen membrane when used for a post-extraction ridge preservation procedure to prevent the bone loss that typically occurs. The hypothesis is that there will be no difference in the clinical and histologic results between the two membranes.
Primary Outcome
The crestal ridge width will be measured with a digital caliper at the baseline exam and at the 4 month examination.
Interventions
- PROCEDURE PTFE membrane
- PROCEDURE Collagen membrane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT01900964 record still lists
NCT01900964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which PTFE membrane is the first listed.
NCT01900964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01900964 about?
NCT01900964 is a clinical study titled "Ridge Preservation Comparing a PTFE Nonresorbable Membrane to a Collagen Membrane". A non-resorbable PTFE (teflon) membrane will be compared to a resorbable collagen membrane when used for a post-extraction ridge preservation procedure to prevent the bone loss that typically occurs. The hypothesis is that there will be no difference in the clinical and histologic results between th...
What is the current status of trial NCT01900964?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-10. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01900964?
The interventions under investigation include: PTFE membrane (PROCEDURE), Collagen membrane (PROCEDURE).
Who is sponsoring clinical trial NCT01900964?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01900964's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia